전립선 비대증 환자에서 항콜린성 약물다제투여 및 중추신경계 부작용 조사
Polypharmacy and Central Nervous System Adverse Effects ofAnticholinergic Agents in the Men with Benign Prostate Hyperplasia
1
조회
0
다운로드
2
인용
0
참고문헌
초록
Abstract
Purpose: Elderly patients commonly receive multiple drugs compared to young patients because of high comorbidity. Some common illnesses in the elderly with underlying diseases are complicated or aggravated by treatment with anticholinergic agents. We evaluated the use of anticholinergic agents and their adverse effects in the men with benign prostate hyperplasia. Materials and Methods: One hundred-eighty four patients over 40 years-old who visited hospital for the treatment of benign prostate hyperplasia and prescribed more than one anticholinergic agent from January 2005 to June 2006 were enrolled. The patients who took anticholinergics during less than 2 months or suffered from psychiatric problems were excluded. One hundred-fifteen patients were included and all prescribed drugs were classified and counted. The number of anticholinomimetic agents and their 10 adverse effects were checked. Results: Mean age was 67.0±10.6 years and mean cormobidity diseases counted 1.1±1.1. Mean pill and mean anticholinergic agents counted 7.3±4.3 and 1.8±1.1, respectively. Prescribed anticholinergic agents count increased with patient's age (p=0.401). As the patients took more medications, they had higher possibility to take anticholinergic agents. And as the patients took more anticholinergic agents, they showed more anticholinergic adverse effects (p＜0.001). Conclusion: Elderly patients mistakenly tend to attribute drug-induced changes in memory and cognitive function to aging or comorbid conditions. Therefore prescribers should consider an anticholinergic agent's receptor selectivity, ability to cross the blood-brain barrier, and pateint's medical history in elderly patients. Additionally physicians can actively perform Mini-Mental Status Examination for evaluation of the patient's cognitive functions under anticholinergic medication. (J. Korean Continence Society 2007;11:24-29)
참고문헌 (14)
- "Prevalence and impact of medical comorbidity in Alzheimer'sdisease.", 57, pp.173~177 (2002)
- "Antimuscarinic agents: implicationsand concerns in the management of overactive bladder in theelderly", 27, pp.127~138 (2005)
- "Chronic anticholinergic toxicity.Identification and management in older patients", 58, pp.36~37 (2003)
- "Central nervous system safety ofanticholinergic drugs for the treatment of overactive bladderin the elderly.", 27, pp.144~153 (2005)
- "effects of age and noncognitiveindividual differences. Psychol Aging 1992", pp.72~82
- "et al. Age-related decreases in muscariniccholinergic receptor binding in the human brain measured withpositron emission tomography", ow nd, pp.569~75
- "Age and sex as factorsmodifying the function of the blood-cerebrospinal fluid barrier", 6, pp.314~318 (2000)
- "Diagnosis and treatment of the overactive bladder", 62, pp.20~27 (2003)
- "Selective cognitivedysfunction in acetylcholine M1 muscarinic receptor mutantmice", 6, pp.51~58 (2003)
- "IncreasedAlzheimer pathology in Parkinson's disease related to antimuscarinicdrugs", 54, pp.235~238 (2003)
- "Cooper T. Anticholinergic effectsof drugs commonly prescribed for the elderly potential meansfor assessing risk of delirium. Am J Psychiatry 1992", pp.1393~4
- "Antimuscarinic drugs for overactivebladder and their potential effects on cognitive function inolder patients", 53, pp.2195~2201 (2005)
- "Coyle JT. Association of postoperative delirium with raisedserum levels of anticholinergic drugs. Lancet 1981", pp.651~3
- "Serum anticholinergic activity in a communitybased sample of older adults", 60, pp.198~203 (2003)